ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

RENE Reneuron Group Plc

3.05
0.00 (0.00%)
27 Sep 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Reneuron Group Plc LSE:RENE London Ordinary Share GB00BF5G6K95 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.05 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 530k -5.41M -0.0946 -0.32 1.74M
Reneuron Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker RENE. The last closing price for Reneuron was 3.05p. Over the last year, Reneuron shares have traded in a share price range of 2.95p to 6.75p.

Reneuron currently has 57,173,760 shares in issue. The market capitalisation of Reneuron is £1.74 million. Reneuron has a price to earnings ratio (PE ratio) of -0.32.

Reneuron Share Discussion Threads

Showing 4276 to 4297 of 8925 messages
Chat Pages: Latest  177  176  175  174  173  172  171  170  169  168  167  166  Older
DateSubjectAuthorDiscuss
02/9/2014
17:48
Just a bit of profit taking,happens everywhere. Looks like a strong future going forward.
bigspuds
02/9/2014
13:12
52ron and yet the share price is down...
stewart_25
02/9/2014
12:49
Cenkos notes that ReNeuron (LON:RENE) has published a confident AGM statement highlighting the fact that the first patients have been dosed in both the stroke (Phase II) and critical (lower) limb ischemia (Phase I) clinical trials.

These are important milestones and ReNeuron has also confirmed the timelines for the completion of both trials, highlighting several key clinical milestones expected to occur over the next 18-24 months.

The broker has retained its buy rating and sees an important number of value inflection points between now and the end of 2015, when six-month follow up clinical data from the Phase II stroke trial for ReN001 should become available.

52ron
02/9/2014
08:33
Everything on track then - second dose of rene1 already administered to one patient. Cannot wait for the news on the outcome of them results....
stewart_25
01/9/2014
12:50
All looking very positive. Just to break through 4p and we're away.
loftgroovv
01/9/2014
11:46
something defo in the pipeline then...
stewart_25
01/9/2014
11:29
A lot of 100,000 AT trades at 4p
curlly
01/9/2014
11:10
Yep. Long way to go yet
bigspuds
01/9/2014
10:45
curly - 14p would be better lol
stewart_25
01/9/2014
10:34
Lets hope we get above 4p and can stay there.
curlly
01/9/2014
10:27
some definite upwards movement... people buying before suspected good news?
stewart_25
29/8/2014
16:29
well summats up!
bigspuds
29/8/2014
15:53
I bought quite a lot more earlier in the week. Just feel after all these years the company has really turned a corner now (both prospects and balance sheet).
loftgroovv
29/8/2014
14:53
fingers crossed verger - need some positives here - been a lot of negativity over the years I have been in - and I don't understand most of it... onwards and upwards!!!
stewart_25
29/8/2014
14:39
Well, I've decided to buy some more.
verger
29/8/2014
14:12
need this to be sustained though... come on rene - lets have some news that will triple the SP!!!
stewart_25
29/8/2014
12:57
Even more so today!
rayrac
27/8/2014
15:09
Seems like growing interest before the AGM.
loftgroovv
26/8/2014
09:20
Been here too long to get carried away with a price hike, but am I being too cautious? Recent rise accompanied by huge volume. Are we about to see a genuine move upwards?
verger
21/8/2014
07:42
Hopefully we are going to sustain the movement up been in here so many years that I have forgotten how long now!!
mhw28865
21/8/2014
00:25
heavy buying underpinning rise........looking good at last
bigspuds
19/8/2014
12:27
" It's clear Mr Woodford has a passion for early stage companies, even though he is used to managing huge funds packed with blue chips from the ftse 100"
peawacks
Chat Pages: Latest  177  176  175  174  173  172  171  170  169  168  167  166  Older